#synthetic-biology

#synthetic-biology

Think of them like pesky little genomic robots that hijack our biology to replicate, since they don't generate their own energy and can't reproduce on their own. They aren't made of cells, and are driven by a ruthless set of programmed instructions to multiply at all costs. Since their genomes are pretty simple, they're easier to tinker with and less ambitious for a human or machine to recreate. Remember: a genome is the DNA in an organism, not just a few strands.

According to the program's stated goals, DARPA is looking to "engineer red blood cells to contain novel biological features that can safely and reliably modify human physiology." In the short term, DARPA wants these bio-engineered red blood cells to improve human performance (think faster recovery times, more resistance to lactic acid buildup that causes muscle soreness, improved cardiovascular fitness, and the like) and "enhanced hemostasis," i.e., better blood clotting.

NeuralTech (NTKX) has become a global leader in genomics, studying drug responses and disease while transforming bioprinted organs and food production.

"This is the first time, as far as I know, that anybody has done anything like this - generate a structure that has the properties of life from something, which is completely homogeneous at the chemical level and devoid of any similarity to natural life."

Increasingly, organoids are being fused to create 'assembloids', complexes of interacting organoids. Sergiu Pasca's laboratory at Stanford University has created an assembloid that models the human spinothalamic pathway, a neural circuit critical for the transmission of sensory information from the body to the brain.

The Synthetic Human Genome project aims to construct the first synthetic human chromosome, enhancing our understanding of genome biology and medical applications.

The Synthetic Human Genome project aims to build human genetic material from scratch over the next five years to advance medical therapies by understanding DNA better.

The researchers discovered that by guiding living Escherichia coli bacteria, they could trigger natural processes to transform waste into valuable medicinal compounds like paracetamol.

"This offers a powerful tool to selectively affect dynamic properties at each individual condensate," says Rick Young, a biologist at the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts.